Boston Resident Diagnosed With Measles; Possible Exposure Locations Identified

BOSTON (CBS) – A Boston resident has the city’s first confirmed case of the measles since 2013. The Public Health Commission announced Wednesday that others may have been exposed at a number of locations in the South End, Fenway and Back Bay neighborhoods. Doctors diagnosed the case on Sunday. Health officials released the following lists of locations in Boston and times where the person could have exposed others: Friday, October 4th 1:30pm to 4:30pm Render Coffee, 563 Columbus Avenue, South End Friday, October 4th 2:30pm to 4:45pm Cafe Madeleine, 517 Columbus Avenue, South End Friday, October 4th 6:30pm to 9:30pm Gyroscope, 305 Huntington Avenue, Fenway Saturday, October 5th 11:30am to 1:35pm CouCou, 24 Union Park Street, South End Saturday, October 5th 12:00pm to 2:15pm Sir Speedy, 827 Boylston Street, Back Bay Anyone who was at those locations could get sick between Oct. 25 and Oct. 26, which is 21 days following the potential exposure. The commission said anyone who was exposed and isn’t sure of their immunization status or begins to develop measles symptoms should contact their healthcare provider. Those who have had the measles or received two doses of measles-containing vaccines are unlikely to get sick. Measles is very contagious and is usually spread through coughing and sneezing. It can stay in the environment for up to two hours after the infected person has left the area. Symptoms include a high fever, runny nose, cough and red eyes, followed by ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated Local Measles Source Type: news

Related Links:

CONCLUSIONS: Xyloglucan/gelose plus ORS was effective and safe in treating acute diarrhea in children. PMID: 33028102 [PubMed - as supplied by publisher]
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
Emergency-use authorizations, a formerly obscure corner of regulatory law, have become a centerpiece of the government ’s response to the pandemic.
Source: NYT - Category: American Health Authors: Tags: your-feed-science Coronavirus Risks and Safety Concerns Food and Drug Administration Hahn, Stephen M (1960- ) Coronavirus (2019-nCoV) Vaccination and Immunization Clinical Trials Drugs (Pharmaceuticals) your-feed-health your-feed-healthc Source Type: news
The use of an immune-system stimulant harvested from shark liver oil in the development of some coronavirus vaccines has animal conservationists pressing for alternatives.(Image credit: Reinhard Dirscherl/ullstein bild via Getty Images)
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news
Authors: Abdeta D, Kebede N, Giday M, Terefe G, Abay SM Abstract Microbial resistance to the few conventional antitrypanosomal drugs, increasing resistance of vectors to insecticides, lack of effective vaccines, and adverse effects of the existing antitrypanosomal drugs justify the urgent need for effective, tolerable, and affordable drugs. We assessed antitrypanosomal effects of the hydromethanolic extract of Echinops kebericho Mesfin roots against Trypanosoma congolense field isolate using in vitro and in vivo techniques. Parasite load, packed cell volume (PCV), body weight, and rectal temperature in Swiss albino...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Phoenix Children ’s Hospital held its fourth annual flu POD (point of distribution) this week, with this year's 13-hour blitz holding a special significance amid the global Covid-19 pandemic. On Oct. 7, nurses began vaccinating employees at 6 a.m. and concluded the one-day event at 7 p.m., vaccinating nearly 5,00 0 people. It’s preparation for another potential mass vaccination event: distribution of a safe and effective vaccine for Covid-19. Click through the photo gallery above to see scenes…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Publication date: Available online 8 October 2020Source: Pulmonary Pharmacology &TherapeuticsAuthor(s): Noriyuki Ohkura, Masaki Fujimura, Johsuke Hara, Yusuke Nakade, Miki Abo, Takashi Sone, Hideharu Kimura, Kazuo Kasahara
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
In this study, we modeled an alternative strategy to amplify tumor antigen-specific TCR transgenic CD8+ T cells through limited application of a long-acting IL-2 fusion protein, mIL-2/mCD25, which selectively targets the high-affinity IL-2R. Here, mice were vaccinated with a tumor antigen and high-dose mIL-2/mCD25 was applied to coincide with the induction of the high affinity IL-2R on tumor-specific T cells. A single high dose of mIL-2/mCD25, but not an equivalent amount of IL-2, amplified the frequency and function of tumor-reactive CD8+ T effector (Teff) and memory cells. These mIL-2/mCD25-dependent effects relied on di...
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
According to officials, the Hyderabad-based vaccine maker applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct phase-3 randomised double-blind placebo-controlled multicentre trial of its COVID-19 vaccine candidate.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
DiscussionThe results of this realist review will be written up according to RAMESES guidelines and disseminated through a stakeholder workshop in Malawi, through conference presentations and peer-reviewed publications. It is intended to improve the understanding of the potential and limits of working through Care Groups globally and among relevant Malawi Ministry of Health staff and the donor and NGO community, both internationally and within Malawi. This systematic review protocol has been submitted for registration on the PROSPERO database (receipt number: 170261).
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
ConclusionsPatients on various solid tumour treatments achieve sero-protection rate congruent with the general population. The sero-protection HIA titres were not sustained at 24  weeks postvaccination.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Coffee | Conferences | Cough | Department of Health | Environmental Health | Eyes | Health | Huntington's Disease | International Medicine & Public Health | Measles | Measles Vaccine | Skin | Sports Medicine | Vaccines